Skip to main content

Vasculitis

Epidemiology

02-06-2022 | EULAR 2022 | Conference coverage | News

Mortality risk may be ‘slightly increased’ in women with polymyalgia rheumatica

Women with polymyalgia rheumatica may have a small increase in the risk for mortality relative to the general population, but not during the first 20 years after diagnosis, according to research presented at the EULAR 2022 Congress in Copenhagen, Denmark.

Rituximab and rheumatology practice in the COVID-19 era

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of SLE

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

New additions to the Adis Journal Club

Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

ACR Convergence 2021

3–9 November: Keep up with the latest news and interviews from the conference.

Febuxostat and cardiovascular risk in people with gout

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Telemedicine in rheumatology

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Get ready for ACR Convergence 2020

ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

27-02-2020 | Behçet’s disease | News

Behçet’s disease more common than previously thought

The prevalence of Behçet’s disease in the UK is higher than previously estimated, and patients with the disease have an elevated risk for developing cardiovascular and cerebrovascular conditions, researchers report.

09-08-2019 | Giant cell arteritis | News

GCA no less common in Black than White individuals

The incidence of giant cell arteritis is similar among Black and White people, suggests an analysis of a cohort from a US tertiary care center.

20-11-2018 | Polymyalgia rheumatica | Article

Comorbidities in polymyalgia rheumatica: A systematic review

Partington R et al. Arthritis Res Ther 2018; 20: 258. doi: 10.1186/s13075-018-1757-y

09-07-2018 | Behçet’s disease | Article

Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: Subgroup analysis of data from the VENOST study

Uluduz D et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key153

30-05-2018 | Vasculitis | Review | Article

CNS vasculitis: An approach to differential diagnosis and management

Byram K, Hajj-Ali RA, Calabrese L. Curr Rheumatol Rep 2018; 20: 37. doi: 10.1007/s11926-018-0747-z

02-04-2018 | Immunoglobulin A vasculitis | Review | Article

IgA vasculitis: Genetics and clinical and therapeutic management

González-Gay MA et al. Curr Rheumatol Rep 2018; 20: 24. doi: 10.1007/s11926-018-0735-3

02-04-2018 | Giant cell arteritis | Review | Article

Recent advances in giant cell arteritis

Guevara M, Kollipara CS. Curr Rheumatol Rep 2018; 20: 25. doi: 10.1007/s11926-018-0737-1

21-03-2018 | Vasculitis | Review | Article

Vasculitis in Africa

Genga E, Oyoo O, Adebajo A. Curr Rheumatol Rep 2018; 20: 4. doi: 10.1007/s11926-018-0711-y

13-02-2018 | Immunoglobulin A vasculitis | Review | Article

IgA vasculitis in adults

Moran SM, Reich HN. Curr Treat Options in Rheum 2018; 4: 119–132. doi: 10.1007/s40674-018-0088-0